CEO, CATHWORKS
WHY: Leads Irvine-based developer of the FFRangio system, which provides X-ray imaging of the coronary artery branch and applies machine learning to help doctors identify coronary issues in a noninvasive manner.
IN THE NEWS: Received this year a $75M investment from Medtronic, one of the world’s largest medical device makers. Agreement provides Medtronic option to buy CathWorks in next five years at a $585M valuation.
NOTABLE: Business Journal’s 2022 Excellence in Entrepreneurship Award winner.
QUOTABLE: “This long-term partnership [with Medtronic] opens up the door for exciting development activities.”
